Search

Author/Creator Galimi, Francesco

2. Telomere length shortening is associated with treatment-free remission in chronic myeloid leukemia patients. Issue 1 (December 2016)

Authors:
Caocci, Giovanni; Greco, Marianna; Delogu, Giuseppe; Secchi, Christian; Martino, Bruno; Labate, Claudia; Abruzzese, Elisabetta; Trawinska, Malgorzata; Galimberti, Sara; Orru, Federica; Fozza, Claudio; Passerini, Carlo; Galimi, Francesco; La Nasa, Giorgio
Journal:
Journal of hematology & oncology
Issue:
Volume 9:Issue 1(2016)
Page Start:
1
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. TRAIL receptor agonist conatumumab with modified FOLFOX6 plus bevacizumab for first‐line treatment of metastatic colorectal cancer. Issue 24 (1st October 2013)

Authors:
Fuchs, Charles S.; Fakih, Marwan; Schwartzberg, Lee; Cohn, Allen L.; Yee, Lorrin; Dreisbach, Luke; Kozloff, Mark F.; Hei, Yong‐jiang; Galimi, Francesco; Pan, Yang; Haddad, Vincent; Hsu, Cheng‐Pang; Sabin, Antony; Saltz, Leonard
Journal:
Cancer
Issue:
Volume 119:Issue 24(2013)
Page Start:
4290
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. TRAIL receptor agonist conatumumab with modified FOLFOX6 plus bevacizumab for first‐line treatment of metastatic colorectal cancer: A randomized phase 1b/2 trial. Issue 24 (1st October 2013)

Authors:
Fuchs, Charles S.; Fakih, Marwan; Schwartzberg, Lee; Cohn, Allen L.; Yee, Lorrin; Dreisbach, Luke; Kozloff, Mark F.; Hei, Yong‐jiang; Galimi, Francesco; Pan, Yang; Haddad, Vincent; Hsu, Cheng‐Pang; Sabin, Antony; Saltz, Leonard
Journal:
Cancer
Issue:
Volume 119:Issue 24(2013)
Page Start:
4290
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗